276 related articles for article (PubMed ID: 31354500)
1. Perspectives Regarding the Role of Biochanin A in Humans.
Yu C; Zhang P; Lou L; Wang Y
Front Pharmacol; 2019; 10():793. PubMed ID: 31354500
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats.
Moon YJ; Sagawa K; Frederick K; Zhang S; Morris ME
AAPS J; 2006 Jul; 8(3):E433-42. PubMed ID: 17025260
[TBL] [Abstract][Full Text] [Related]
3. Chemical and Biological Properties of Biochanin A and Its Pharmaceutical Applications.
Feng ZJ; Lai WF
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111591
[TBL] [Abstract][Full Text] [Related]
4. Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
Fokialakis N; Alexi X; Aligiannis N; Siriani D; Meligova AK; Pratsinis H; Mitakou S; Alexis MN
Bioorg Med Chem; 2012 May; 20(9):2962-70. PubMed ID: 22464681
[TBL] [Abstract][Full Text] [Related]
5. Enhancing the oral bioavailability of biochanin A by encapsulation in mixed micelles containing Pluronic F127 and Plasdone S630.
Wu X; Ge W; Shao T; Wu W; Hou J; Cui L; Wang J; Zhang Z
Int J Nanomedicine; 2017; 12():1475-1483. PubMed ID: 28260893
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
Moon YJ; Morris ME
Mol Pharm; 2007; 4(6):865-72. PubMed ID: 17970592
[TBL] [Abstract][Full Text] [Related]
7. Biochanin A from Chinese Medicine: An Isoflavone with Diverse Pharmacological Properties.
Yan J; Qiu P; Zhang X; Zhang Y; Mi L; Peng C; Pan X; Peng F
Am J Chin Med; 2021; 49(7):1623-1643. PubMed ID: 34530697
[TBL] [Abstract][Full Text] [Related]
8. Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30/PKA-Dependent Mechanism.
Felix FB; Vago JP; Fernandes DO; Martins DG; Moreira IZ; Gonçalves WA; Costa WC; Araújo JMD; Queiroz-Junior CM; Campolina-Silva GH; Soriani FM; Sousa LP; Grespan R; Teixeira MM; Pinho V
Front Pharmacol; 2021; 12():662308. PubMed ID: 33995086
[TBL] [Abstract][Full Text] [Related]
9. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A.
Wang L; Luo Q; Lin T; Li R; Zhu T; Zhou K; Ji Z; Song J; Jia B; Zhang C; Chen W; Zhu G
Drug Dev Ind Pharm; 2015; 41(7):1204-12. PubMed ID: 25010850
[TBL] [Abstract][Full Text] [Related]
10. Reduced bioavailability of tamoxifen and its metabolite 4-hydroxytamoxifen after oral administration with biochanin A (an isoflavone) in rats.
Singh SP; Wahajuddin ; Raju KS; Ali MM; Kohli K; Jain GK
Phytother Res; 2012 Feb; 26(2):303-7. PubMed ID: 22131128
[TBL] [Abstract][Full Text] [Related]
11. In vivo prediction of CYP-mediated metabolic interaction potential of formononetin and biochanin A using in vitro human and rat CYP450 inhibition data.
Arora S; Taneja I; Challagundla M; Raju KS; Singh SP; Wahajuddin M
Toxicol Lett; 2015 Nov; 239(1):1-8. PubMed ID: 26278343
[TBL] [Abstract][Full Text] [Related]
12. Formononetin and biochanin A protects against ritonavir induced hepatotoxicity via modulation of NfκB/pAkt signaling molecules.
Alauddin ; Chaturvedi S; Malik MY; Azmi L; Shukla I; Naseem Z; Rao C; Agarwal NK
Life Sci; 2018 Nov; 213():174-182. PubMed ID: 30326221
[TBL] [Abstract][Full Text] [Related]
13. Biochanin A induction of sulfotransferases in rats.
Chen Y; Huang C; Zhou T; Zhang S; Chen G
J Biochem Mol Toxicol; 2010; 24(2):102-14. PubMed ID: 20391625
[TBL] [Abstract][Full Text] [Related]
14. A biochanin-enriched isoflavone from red clover lowers LDL cholesterol in men.
Nestel P; Cehun M; Chronopoulos A; DaSilva L; Teede H; McGrath B
Eur J Clin Nutr; 2004 Mar; 58(3):403-8. PubMed ID: 14985677
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and antimicrobial activity of inclusion complex of biochanin A with (2-hydroxypropyl)-β-cyclodextrin.
Nikolic IL; Savic IM; Popsavin MM; Rakic SJ; Mihajilov-Krstev TM; Ristic IS; Eric SP; Savić-Gajic IM
J Pharm Pharmacol; 2018 Nov; 70(11):1485-1493. PubMed ID: 30168133
[TBL] [Abstract][Full Text] [Related]
16. Nanostructured lipid carriers as a delivery system of biochanin A.
Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W
Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887
[TBL] [Abstract][Full Text] [Related]
17. Effect of biochanin A on corn grain (Zea mays) fermentation by bovine rumen amylolytic bacteria.
Harlow BE; Flythe MD; Aiken GE
J Appl Microbiol; 2017 Apr; 122(4):870-880. PubMed ID: 28055130
[TBL] [Abstract][Full Text] [Related]
18. The dietary isoflavone biochanin-A sensitizes prostate cancer cells to TRAIL-induced apoptosis.
Szliszka E; Czuba ZP; Mertas A; Paradysz A; Krol W
Urol Oncol; 2013 Apr; 31(3):331-42. PubMed ID: 21803611
[TBL] [Abstract][Full Text] [Related]
19. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression.
Wang Y; Man Gho W; Chan FL; Chen S; Leung LK
Br J Nutr; 2008 Feb; 99(2):303-10. PubMed ID: 17761019
[TBL] [Abstract][Full Text] [Related]
20. Harnessing Therapeutic Potentials of Biochanin A in Neurological Disorders: Pharmacokinetic and Pharmacodynamic Overview.
Kumar A; Angelopoulou E; Pyrgelis ES; Piperi C; Mishra A
Chem Biodivers; 2024 Jun; ():e202400709. PubMed ID: 38828832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
